Targeted therapies for triple-negative breast cancer: combating a stubborn disease

M Kalimutho, K Parsons, D Mittal, JA López… - Trends in …, 2015 - cell.com
Triple-negative breast cancers (TNBCs) constitute a heterogeneous subtype of breast
cancers that have a poor clinical outcome. Although no approved targeted therapy is …

Targeting the cell cycle in breast cancer: towards the next phase

KL Thu, I Soria-Bretones, TW Mak, DW Cescon - Cell Cycle, 2018 - Taylor & Francis
Deregulation of the cell cycle is a hallmark of cancer that enables limitless cell division. To
support this malignant phenotype, cells acquire molecular alterations that abrogate or …

[HTML][HTML] DGCA: a comprehensive R package for differential gene correlation analysis

AT McKenzie, I Katsyv, WM Song, M Wang… - BMC systems …, 2016 - Springer
Background Dissecting the regulatory relationships between genes is a critical step towards
building accurate predictive models of biological systems. A powerful approach towards this …

Mechanisms of genomic instability in breast cancer

PHG Duijf, D Nanayakkara, K Nones, S Srihari… - Trends in molecular …, 2019 - cell.com
Breast cancer is the most common cancer among women globally. Genomic instability (GI)
refers to the increased tendency to accrue genomic alterations. It drives heterogeneity and is …

Beyond cytokinesis: the emerging roles of CEP55 in tumorigenesis

J Jeffery, D Sinha, S Srihari, M Kalimutho, KK Khanna - Oncogene, 2016 - nature.com
CEP55 was initially identified as a pivotal component of abscission, the final stage of
cytokinesis, serving to regulate the physical separation of two daughter cells. Over the past …

[HTML][HTML] Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model

ARR Maia, J de Man, U Boon, A Janssen, JY Song… - Annals of …, 2015 - Elsevier
Background Triple-negative breast cancers (TNBC) are considered the most aggressive
type of breast cancer, for which no targeted therapy exists at the moment. These tumors are …

Effects of aneuploidy on gene expression: implications for cancer

M Dürrbaum, Z Storchová - The FEBS journal, 2016 - Wiley Online Library
Unbalanced chromosome content, so‐called aneuploidy, is a hallmark of cancer cells.
Changes in the copy numbers of chromosomes or large chromosomal regions significantly …

CEP 55 is a determinant of cell fate during perturbed mitosis in breast cancer

M Kalimutho, D Sinha, J Jeffery, K Nones… - EMBO molecular …, 2018 - embopress.org
The centrosomal protein, CEP 55, is a key regulator of cytokinesis, and its overexpression is
linked to genomic instability, a hallmark of cancer. However, the mechanism by which it …

Aggressive serous epithelial ovarian cancer is potentially propagated by EpCAM+CD45+ phenotype

MZ Akhter, SK Sharawat, V Kumar, V Kochat, Z Equbal… - Oncogene, 2018 - nature.com
Epithelial ovarian carcinoma (EOC) patients often acquire resistance against common
chemotherapeutic drugs like paclitaxel and cisplatin. The mechanism responsible for the …

[HTML][HTML] Druggable molecular targets for the treatment of triple negative breast cancer

M Nakhjavani, JE Hardingham… - Journal of breast …, 2019 - synapse.koreamed.org
Breast cancer (BC) is still the most common cancer among women worldwide. Amongst the
subtypes of BC, triple negative breast cancer (TNBC) is characterized by deficient …